Aflac Incorporated (AFL)
Last closing price (Mar 28 4:00 EDT):
72.31 (0.65%) ?
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also offers products designed to protect individuals from depletion of assets, which comprise accident, cancer, critical illness/critical care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans; and loss-of-income products, such as life and short-term disability plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
|Eric Berg||RBC Capital Markets||Sell||Feb 02, '17||67.41||62.00||Feb 02, '18||-7.27%|
|Eric Berg||RBC Capital Markets||Sell||Dec 08, '16||69.19||Dec 08, '17||-4.51%|
|Sean Dargan||Macquarie Research Equities||Buy||Apr 14, '16||65.40||Apr 14, '17||10.57%|
|Randy Binner||FBR Capital Markets & Co.||Buy||Feb 01, '16||55.13||Feb 01, '17||N/A|
|Ryan Krueger||Dowling & Partners Securities, LLC||Buy||Oct 12, '15||59.31||69.00||Oct 12, '16||19.68%|
|Jeffrey Schuman||Keefe, Bruyette & Woods||Buy||Aug 27, '15||57.17||68.00||Aug 27, '16||27.25%|
|Greg Poole||Deutsche Bank Securities||Buy||Feb 10, '14||60.90||Feb 10, '15||0.39%|
|Jay Gelb||Barclays||Buy||Jan 07, '14||63.50||78.00||Jan 07, '15||-7.17%|
|Jeffrey Schuman||Keefe, Bruyette & Woods||Buy||Oct 21, '13||63.97||83.00||Oct 21, '14||-10.55%|
|Jay Gelb||Barclays||Buy||Oct 07, '13||61.45||75.00||Oct 07, '14||-5.94%|
|Randy Binner||FBR Capital Markets & Co.||Buy||Oct 01, '13||61.94||71.00||Oct 01, '14||-5.96%|
|Jeffrey Schuman||Keefe, Bruyette & Woods||Buy||Jul 18, '13||57.96||76.00||Jul 18, '14||9.01%|
|Mark Finkelstein||Evercore Partners||Buy||Jul 15, '13||57.54||68.00||Jul 15, '14||15.45%|
|John Nadel||Sterne, Agee & Leach||Buy||Jun 14, '13||56.19||Jun 14, '14||10.27%|
|Edward Shields||Sandler O'Neill & Partners L.P.||Buy||May 23, '13||53.79||62.00||May 23, '14||15.00%|
|John Nadel||Sterne, Agee & Leach||Buy||Apr 25, '13||51.34||65.00||Apr 25, '14||23.64%|
|Mark Finkelstein||Evercore Partners||Buy||Apr 18, '13||47.76||61.00||Apr 18, '14||32.01%|
|Jay Gelb||Barclays||Buy||Apr 01, '13||50.93||65.00||Apr 01, '14||24.64%|
|Mark Finkelstein||Evercore Partners||Buy||Feb 28, '13||48.79||61.00||Feb 28, '14||29.90%|
|Jay Gelb||Barclays||Buy||Jan 02, '13||52.75||65.00||Jan 02, '14||26.64%|